Skip to main content

Ankeet Shah

Assistant Professor of Urology
Urology
DUMC 3707, Durham, NC 27710
40 Duke Medicine Circle, Duke Clinics 1st FLR. Room 1080, Durham, NC 27710

Selected Publications


Advanced chronic kidney disease; A comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma.

Journal Article Urol Oncol · June 2023 PURPOSE: Renal function outcomes between radical nephroureterectomy (RNU) and nephron-sparing surgery (NSS) for upper tract urothelial carcinoma (UTUC) patients are not well established. We sought to compare the incidence and factors associated with develo ... Full text Link to item Cite

Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage.

Journal Article Urol Oncol · August 2021 PURPOSE: Intravesical Bacillus Calmette-Guérin (BCG) is the gold standard for intermediate and high-risk non-muscle invasive bladder cancer (NMIBC), but availability is limited by global shortages. We present the first North American clinical experience us ... Full text Open Access Link to item Cite

Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions.

Journal Article World J Urol · May 2021 OBJECTIVES: To evaluate three subtypes of continent-cutaneous urinary diversion (CCUD); Indiana pouch (IP), right colon pouch with appendico-umbilicostomy (AU), and right colon pouch with neo-appendico-umbilicostomy (NAU), by investigating diversion-specif ... Full text Link to item Cite

Classification of Molecular Biomarkers

Journal Article Société Internationale d’Urologie Journal · October 13, 2020 A “biomarker” is any measurable characteristic that indicates the presence or absence of disease or the biological response to a stimulus, typically an exposure or intervention. The FDA-NIH Biomarker Working Group has produced a document called Bio ... Full text Cite

Assessments of frailty in bladder cancer.

Journal Article Urol Oncol · September 2020 BACKGROUND AND AIMS: The incidence of frailty is increasing as the population ages, which has important clinical implications given the associations between frailty and poor outcomes in the bladder cancer population. Due to a multi-organ system decline and ... Full text Open Access Link to item Cite

Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.

Journal Article Eur Urol Focus · July 15, 2020 GemRIS, an implantable drug delivery system from Taris Biomedical that delivers continuous intravesical gemcitabine, shows potential for use in multiple bladder cancer settings. Ongoing and recently completed phase 1 trials in non-muscle-invasive as well a ... Full text Open Access Link to item Cite

Hyperthermia Improves Solubility of Intravesical Chemotherapeutic Agents.

Journal Article Bladder Cancer · 2020 BACKGROUND: Nearly 70% of all new cases of bladder cancer are non-muscle invasive disease, the treatment for which includes transurethral resection followed by intravesical therapy. Unfortunately, recurrence rates approach 50% in part due to poor intravesi ... Full text Open Access Link to item Cite

Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathway.

Journal Article Urol Oncol · September 2019 PURPOSE: To characterize drivers of ICU admission during index hospitalization after Radical Cystectomy (RC) with Enhanced Recovery After Surgery (ERAS) protocol, as well as corresponding outcomes. METHODS: A retrospective review of an IRB-approved cystect ... Full text Link to item Cite

Management of extraretroperitoneal masses in germ cell tumor.

Journal Article Curr Opin Urol · January 2019 PURPOSE OF REVIEW: Management of extraretroperitoneal (ERP) germ cell tumor (GCT) is a complex clinical scenario faced by urologic oncologists. This article reviews the indications and approach to management of ERP GCT masses. RECENT FINDINGS: ERP GCT mana ... Full text Link to item Cite

Advanced chronic kidney disease; A comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma.

Journal Article Urol Oncol · June 2023 PURPOSE: Renal function outcomes between radical nephroureterectomy (RNU) and nephron-sparing surgery (NSS) for upper tract urothelial carcinoma (UTUC) patients are not well established. We sought to compare the incidence and factors associated with develo ... Full text Link to item Cite

Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage.

Journal Article Urol Oncol · August 2021 PURPOSE: Intravesical Bacillus Calmette-Guérin (BCG) is the gold standard for intermediate and high-risk non-muscle invasive bladder cancer (NMIBC), but availability is limited by global shortages. We present the first North American clinical experience us ... Full text Open Access Link to item Cite

Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions.

Journal Article World J Urol · May 2021 OBJECTIVES: To evaluate three subtypes of continent-cutaneous urinary diversion (CCUD); Indiana pouch (IP), right colon pouch with appendico-umbilicostomy (AU), and right colon pouch with neo-appendico-umbilicostomy (NAU), by investigating diversion-specif ... Full text Link to item Cite

Classification of Molecular Biomarkers

Journal Article Société Internationale d’Urologie Journal · October 13, 2020 A “biomarker” is any measurable characteristic that indicates the presence or absence of disease or the biological response to a stimulus, typically an exposure or intervention. The FDA-NIH Biomarker Working Group has produced a document called Bio ... Full text Cite

Assessments of frailty in bladder cancer.

Journal Article Urol Oncol · September 2020 BACKGROUND AND AIMS: The incidence of frailty is increasing as the population ages, which has important clinical implications given the associations between frailty and poor outcomes in the bladder cancer population. Due to a multi-organ system decline and ... Full text Open Access Link to item Cite

Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.

Journal Article Eur Urol Focus · July 15, 2020 GemRIS, an implantable drug delivery system from Taris Biomedical that delivers continuous intravesical gemcitabine, shows potential for use in multiple bladder cancer settings. Ongoing and recently completed phase 1 trials in non-muscle-invasive as well a ... Full text Open Access Link to item Cite

Hyperthermia Improves Solubility of Intravesical Chemotherapeutic Agents.

Journal Article Bladder Cancer · 2020 BACKGROUND: Nearly 70% of all new cases of bladder cancer are non-muscle invasive disease, the treatment for which includes transurethral resection followed by intravesical therapy. Unfortunately, recurrence rates approach 50% in part due to poor intravesi ... Full text Open Access Link to item Cite

Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathway.

Journal Article Urol Oncol · September 2019 PURPOSE: To characterize drivers of ICU admission during index hospitalization after Radical Cystectomy (RC) with Enhanced Recovery After Surgery (ERAS) protocol, as well as corresponding outcomes. METHODS: A retrospective review of an IRB-approved cystect ... Full text Link to item Cite

Management of extraretroperitoneal masses in germ cell tumor.

Journal Article Curr Opin Urol · January 2019 PURPOSE OF REVIEW: Management of extraretroperitoneal (ERP) germ cell tumor (GCT) is a complex clinical scenario faced by urologic oncologists. This article reviews the indications and approach to management of ERP GCT masses. RECENT FINDINGS: ERP GCT mana ... Full text Link to item Cite

Use of Automated Performance Metrics to Measure Surgeon Performance during Robotic Vesicourethral Anastomosis and Methodical Development of a Training Tutorial.

Journal Article J Urol · October 2018 PURPOSE: We sought to develop and validate automated performance metrics to measure surgeon performance of vesicourethral anastomosis during robotic assisted radical prostatectomy. Furthermore, we sought to methodically develop a standardized training tuto ... Full text Link to item Cite

Telementoring and Telesurgery for Minimally Invasive Procedures.

Journal Article J Urol · February 2018 PURPOSE: Tremendous interest and need lie at the intersection of telemedicine and minimally invasive surgery. Robotics provides an ideal environment for surgical telementoring and telesurgery given its endoscopic optics and mechanized instrument movement. ... Full text Link to item Cite